These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects. Atlasz T; Szabadfi K; Kiss P; Racz B; Gallyas F; Tamas A; Gaal V; Marton Z; Gabriel R; Reglodi D Ann N Y Acad Sci; 2010 Jul; 1200():128-39. PubMed ID: 20633141 [TBL] [Abstract][Full Text] [Related]
8. Characterizations of a synthetic pituitary adenylate cyclase-activating polypeptide analog displaying potent neuroprotective activity and reduced in vivo cardiovascular side effects in a Parkinson's disease model. Lamine A; Létourneau M; Doan ND; Maucotel J; Couvineau A; Vaudry H; Chatenet D; Vaudry D; Fournier A Neuropharmacology; 2016 Sep; 108():440-50. PubMed ID: 26006268 [TBL] [Abstract][Full Text] [Related]
9. Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases. Lee EH; Seo SR BMB Rep; 2014 Jul; 47(7):369-75. PubMed ID: 24856828 [TBL] [Abstract][Full Text] [Related]
11. Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates. Jolivel V; Basille M; Aubert N; de Jouffrey S; Ancian P; Le Bigot JF; Noack P; Massonneau M; Fournier A; Vaudry H; Gonzalez BJ; Vaudry D Neuroscience; 2009 May; 160(2):434-51. PubMed ID: 19236905 [TBL] [Abstract][Full Text] [Related]
12. Receptor-independent cellular uptake of pituitary adenylate cyclase-activating polypeptide. Doan ND; Chatenet D; Létourneau M; Vaudry H; Vaudry D; Fournier A Biochim Biophys Acta; 2012 Apr; 1823(4):940-9. PubMed ID: 22343001 [TBL] [Abstract][Full Text] [Related]
14. Role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the action of ginsenoside Rh2 against beta-amyloid-induced inhibition of rat brain astrocytes. Shieh PC; Tsao CW; Li JS; Wu HT; Wen YJ; Kou DH; Cheng JT Neurosci Lett; 2008 Mar; 434(1):1-5. PubMed ID: 18313848 [TBL] [Abstract][Full Text] [Related]
18. Involvement of endogenous antioxidant systems in the protective activity of pituitary adenylate cyclase-activating polypeptide against hydrogen peroxide-induced oxidative damages in cultured rat astrocytes. Douiri S; Bahdoudi S; Hamdi Y; Cubì R; Basille M; Fournier A; Vaudry H; Tonon MC; Amri M; Vaudry D; Masmoudi-Kouki O J Neurochem; 2016 Jun; 137(6):913-30. PubMed ID: 26991551 [TBL] [Abstract][Full Text] [Related]
19. Neurotrophic and neuroprotective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on mesencephalic dopaminergic neurons. Takei N; Skoglösa Y; Lindholm D J Neurosci Res; 1998 Dec; 54(5):698-706. PubMed ID: 9843161 [TBL] [Abstract][Full Text] [Related]
20. Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo. Reglodi D; Kiss P; Lubics A; Tamas A Curr Pharm Des; 2011; 17(10):962-72. PubMed ID: 21524257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]